Sotac Pharmaceuticals Limited — Outcome of Board Meeting

Sotac Pharmaceuticals has informed exchanges that its Board of Directors approved the draft Directors' Report and the Notice convening the company's 11th Annual General Meeting (AGM). This formal step signals the company's preparation to present its annual financial performance and business strategy to its shareholders. The AGM is a key event where the board seeks approval for past year's accounts and other corporate matters.

For investors, this update confirms that Sotac is on track to complete its standard annual corporate governance cycle. It provides an opportunity for shareholders to review the company's operational progress and future outlook. The meeting itself will be held on September 07, 2026, as per the notice approved by the board.

Moving forward, investors should watch for the actual AGM date and any significant announcements made during the meeting. This includes updates on the company's financial health, dividend declarations, or strategic plans for the upcoming year. The AGM serves as a primary channel for management to communicate directly with the investor base.